Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141

JL. Hsu, DJ. van den Boomen, P. Tomasec, MP. Weekes, R. Antrobus, RJ. Stanton, E. Ruckova, D. Sugrue, GS. Wilkie, AJ. Davison, GW. Wilkinson, PJ. Lehner,

. 2015 ; 11 (4) : e1004811. [pub] 20150414

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16010333

Human cytomegalovirus (HCMV) US2, US3, US6 and US11 act in concert to prevent immune recognition of virally infected cells by CD8+ T-lymphocytes through downregulation of MHC class I molecules (MHC-I). Here we show that US2 function goes far beyond MHC-I degradation. A systematic proteomic study using Plasma Membrane Profiling revealed US2 was unique in downregulating additional cellular targets, including: five distinct integrin α-chains, CD112, the interleukin-12 receptor, PTPRJ and thrombomodulin. US2 recruited the cellular E3 ligase TRC8 to direct the proteasomal degradation of all its targets, reminiscent of its degradation of MHC-I. Whereas integrin α-chains were selectively degraded, their integrin β1 binding partner accumulated in the ER. Consequently integrin signaling, cell adhesion and migration were strongly suppressed. US2 was necessary and sufficient for degradation of the majority of its substrates, but remarkably, the HCMV NK cell evasion function UL141 requisitioned US2 to enhance downregulation of the NK cell ligand CD112. UL141 retained CD112 in the ER from where US2 promoted its TRC8-dependent retrotranslocation and degradation. These findings redefine US2 as a multifunctional degradation hub which, through recruitment of the cellular E3 ligase TRC8, modulates diverse immune pathways involved in antigen presentation, NK cell activation, migration and coagulation; and highlight US2's impact on HCMV pathogenesis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010333
003      
CZ-PrNML
005      
20160418102421.0
007      
ta
008      
160408s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.ppat.1004811 $2 doi
024    7_
$a 10.1371/journal.ppat.1004811 $2 doi
035    __
$a (PubMed)25875600
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hsu, Jye-Lin $u Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
245    10
$a Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141 / $c JL. Hsu, DJ. van den Boomen, P. Tomasec, MP. Weekes, R. Antrobus, RJ. Stanton, E. Ruckova, D. Sugrue, GS. Wilkie, AJ. Davison, GW. Wilkinson, PJ. Lehner,
520    9_
$a Human cytomegalovirus (HCMV) US2, US3, US6 and US11 act in concert to prevent immune recognition of virally infected cells by CD8+ T-lymphocytes through downregulation of MHC class I molecules (MHC-I). Here we show that US2 function goes far beyond MHC-I degradation. A systematic proteomic study using Plasma Membrane Profiling revealed US2 was unique in downregulating additional cellular targets, including: five distinct integrin α-chains, CD112, the interleukin-12 receptor, PTPRJ and thrombomodulin. US2 recruited the cellular E3 ligase TRC8 to direct the proteasomal degradation of all its targets, reminiscent of its degradation of MHC-I. Whereas integrin α-chains were selectively degraded, their integrin β1 binding partner accumulated in the ER. Consequently integrin signaling, cell adhesion and migration were strongly suppressed. US2 was necessary and sufficient for degradation of the majority of its substrates, but remarkably, the HCMV NK cell evasion function UL141 requisitioned US2 to enhance downregulation of the NK cell ligand CD112. UL141 retained CD112 in the ER from where US2 promoted its TRC8-dependent retrotranslocation and degradation. These findings redefine US2 as a multifunctional degradation hub which, through recruitment of the cellular E3 ligase TRC8, modulates diverse immune pathways involved in antigen presentation, NK cell activation, migration and coagulation; and highlight US2's impact on HCMV pathogenesis.
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a buněčná membrána $x metabolismus $7 D002462
650    _2
$a vysokoúčinná kapalinová chromatografie $7 D002851
650    _2
$a Cytomegalovirus $x imunologie $7 D003587
650    _2
$a průtoková cytometrie $7 D005434
650    _2
$a lidé $7 D006801
650    _2
$a imunitní únik $x imunologie $7 D057131
650    _2
$a imunoblotting $7 D015151
650    _2
$a imunoprecipitace $7 D047468
650    _2
$a buňky NK $x imunologie $7 D007694
650    _2
$a aktivace lymfocytů $x imunologie $7 D008213
650    _2
$a hmotnostní spektrometrie $7 D013058
650    _2
$a membránové glykoproteiny $x metabolismus $7 D008562
650    _2
$a membránové proteiny $x metabolismus $7 D008565
650    _2
$a proteomika $x metody $7 D040901
650    _2
$a malá interferující RNA $7 D034741
650    _2
$a transdukce genetická $7 D014161
650    _2
$a proteiny virového obalu $x metabolismus $7 D014759
650    _2
$a virové proteiny $x metabolismus $7 D014764
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a van den Boomen, Dick J H $u Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a Tomasec, Peter $u School of Medicine, Cardiff University, Cardiff, United Kingdom.
700    1_
$a Weekes, Michael P $u Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a Antrobus, Robin $u Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom. $7 gn_A_00007582
700    1_
$a Stanton, Richard J $u School of Medicine, Cardiff University, Cardiff, United Kingdom.
700    1_
$a Ruckova, Eva $u Regional Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Brno, Czech Republic.
700    1_
$a Sugrue, Daniel $u School of Medicine, Cardiff University, Cardiff, United Kingdom.
700    1_
$a Wilkie, Gavin S $u MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
700    1_
$a Davison, Andrew J $u MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
700    1_
$a Wilkinson, Gavin W G $u School of Medicine, Cardiff University, Cardiff, United Kingdom.
700    1_
$a Lehner, Paul J $u Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
773    0_
$w MED00008922 $t PLoS pathogens $x 1553-7374 $g Roč. 11, č. 4 (2015), s. e1004811
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25875600 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160418102508 $b ABA008
999    __
$a ok $b bmc $g 1113762 $s 934701
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 11 $c 4 $d e1004811 $e 20150414 $i 1553-7374 $m PLOS pathogens $n PLoS Pathog $x MED00008922
LZP    __
$a Pubmed-20160408
Zpět

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace